NDC 51662-1242
NALOXONE HCI
Naloxone Hci
NALOXONE HCI is a Intramuscular; Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co. Llc, Dba Health First. The primary component is Naloxone Hydrochloride.
Product ID | 51662-1242_80625ecc-d6b5-74fc-e053-2991aa0a4776 |
NDC | 51662-1242 |
Product Type | Human Prescription Drug |
Proprietary Name | NALOXONE HCI |
Generic Name | Naloxone Hci |
Dosage Form | Injection, Solution |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Marketing Start Date | 2018-08-18 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA070254 |
Labeler Name | HF Acquisition Co. LLC, DBA Health First |
Substance Name | NALOXONE HYDROCHLORIDE |
Active Ingredient Strength | 0 mg/mL |
Pharm Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |